Farr Miller Washingtondc Lowers stake in Colgate-Palmolive Company (CL)

Colgate-Palmolive Company (CL) : Farr Miller Washingtondc reduced its stake in Colgate-Palmolive Company by 0.05% during the most recent quarter end. The investment management company now holds a total of 344,726 shares of Colgate-Palmolive Company which is valued at $25,844,108 after selling 166 shares in Colgate-Palmolive Company , the firm said in a disclosure report filed with the SEC on Aug 10, 2016.Colgate-Palmolive Company makes up approximately 2.82% of Farr Miller Washingtondc’s portfolio.

Other Hedge Funds, Including , Carret Asset Management reduced its stake in CL by selling 375 shares or 1.79% in the most recent quarter. The Hedge Fund company now holds 20,578 shares of CL which is valued at $1,542,733. Colgate-Palmolive Company makes up approx 0.28% of Carret Asset Management’s portfolio.Schnieders Capital Management reduced its stake in CL by selling 349 shares or 1.63% in the most recent quarter. The Hedge Fund company now holds 21,022 shares of CL which is valued at $1,574,338. Colgate-Palmolive Company makes up approx 0.86% of Schnieders Capital Management’s portfolio.Ropes Wealth Advisors boosted its stake in CL in the latest quarter, The investment management firm added 10,923 additional shares and now holds a total of 17,752 shares of Colgate-Palmolive Company which is valued at $1,329,447. Colgate-Palmolive Company makes up approx 0.45% of Ropes Wealth Advisors’s portfolio.First Manhattan Co reduced its stake in CL by selling 11,042 shares or 4.39% in the most recent quarter. The Hedge Fund company now holds 240,623 shares of CL which is valued at $17,926,414. Colgate-Palmolive Company makes up approx 0.11% of First Manhattan Co’s portfolio.

Colgate-Palmolive Company closed down -0.1 points or -0.13% at $74.49 with 20,88,609 shares getting traded on Friday. Post opening the session at $74.33, the shares hit an intraday low of $74.09 and an intraday high of $74.51 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.

On the company’s financial health, Colgate-Palmolive Company reported $0.70 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Jul 28, 2016. Analyst had a consensus of $0.69. The company had revenue of $3845.00 million for the quarter, compared to analysts expectations of $3859.81 million. The company’s revenue was down -5.4 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $0.70 EPS.

Many Wall Street Analysts have commented on Colgate-Palmolive Company. Colgate-Palmolive Company was Downgraded by Exane BNP Paribas to ” Neutral” on Jul 29, 2016.

Colgate-Palmolive Company (Colgate) is a consumer products company whose products are marketed in more than 200 countries and territories throughout the world. The Company operates in two product segments: Oral Personal and Home Care and Pet Nutrition. The Oral Personal and Home Care product segment is operated through five geographic segments: North America Latin America Europe/South Pacific Asia and Africa/Eurasia. The Company’s oral care products include Colgate Total; Colgate Sensitive Pro-Relief; Colgate Max Fresh; Colgate Optic White and Colgate Luminous White toothpastes among others. The Company sells its personal care products under the Palmolive Protex and Softsoap brands. The Company through its Hill’s Pet Nutrition segment (Hill’s) manufactures pet nutrition products for dogs and cats.

Leave a Reply

Colgate-Palmolive Company - Is it time to Sell?

Top Brokerage Firms are advising their investors on Colgate-Palmolive Company. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.